• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Practices in the management of kidney transplant candidates and recipients with obesity: A survey of United States transplant programs.肥胖肾移植候选者及受者的管理实践:美国移植项目调查
Am J Transplant. 2025 May 31. doi: 10.1016/j.ajt.2025.05.033.
2
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
3
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
4
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.在初级保健中使用药物治疗肥胖患者的临床效果和成本效益如何?系统评价。
Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050.
5
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity.改变卫生专业人员行为及护理组织方式的干预措施,以促进超重或肥胖儿童及成人减轻体重。
Cochrane Database Syst Rev. 2017 Nov 30;11(11):CD000984. doi: 10.1002/14651858.CD000984.pub3.
6
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.
7
Evaluation of the ventricular assist device programme in the UK.英国心室辅助装置项目评估
Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. doi: 10.3310/hta10480.
8
Interventions for preventing weight gain after smoking cessation.戒烟后预防体重增加的干预措施。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi: 10.1002/14651858.CD006219.pub3.
9
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

本文引用的文献

1
Transition of Care of Stable Kidney Transplant Patients to Referring Nephrologists: A Survey of U.S. Transplant Program Staff.稳定期肾移植患者向转诊肾病专家过渡的研究:对美国移植项目工作人员的调查。
Clin Transplant. 2024 Nov;38(11):e15484. doi: 10.1111/ctr.15484.
2
ASN Kidney Health Guidance on the Management of Obesity in Persons Living with Kidney Diseases.美国肾脏病学会(ASN)关于肾脏病患者肥胖管理的健康指南。
J Am Soc Nephrol. 2024 Nov 1;35(11):1574-1588. doi: 10.1681/ASN.0000000512. Epub 2024 Sep 18.
3
Economic evaluation of weight loss and transplantation strategies for kidney transplant candidates with obesity.肥胖的肾移植候选者的减肥和移植策略的经济评估。
Am J Transplant. 2024 Dec;24(12):2212-2224. doi: 10.1016/j.ajt.2024.07.024. Epub 2024 Jul 30.
4
OPTN/SRTR 2022 Annual Data Report: Kidney.OPTN/SRTR 2022 年度数据报告:肾脏。
Am J Transplant. 2024 Feb;24(2S1):S19-S118. doi: 10.1016/j.ajt.2024.01.012.
5
Patient and Health Care Professional Perspectives on Addressing Obesity in ESKD.患者和医疗保健专业人员对终末期肾病中肥胖问题的看法。
Am J Kidney Dis. 2023 Oct;82(4):419-428. doi: 10.1053/j.ajkd.2023.02.005. Epub 2023 Apr 20.
6
Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States.美国当前移植中心关于新冠病毒疫苗强制接种规定的实践调查。
Am J Transplant. 2022 Jun;22(6):1705-1713. doi: 10.1111/ajt.16995. Epub 2022 Mar 1.
7
Recipient obesity as a risk factor in kidney transplantation.受者肥胖作为肾移植的一个危险因素。
BMC Nephrol. 2022 Jan 18;23(1):37. doi: 10.1186/s12882-022-02668-z.
8
Population-based Trends in Obesity and Kidney Transplantation Among Patients With End-stage Kidney Disease.终末期肾病患者中基于人群的肥胖与肾移植趋势
Transplant Direct. 2021 Nov 17;7(12):e787. doi: 10.1097/TXD.0000000000001163. eCollection 2021 Dec.
9
Obesity as an isolated contraindication to kidney transplantation in the end-stage renal disease population: A cohort study.肥胖作为终末期肾病患者肾移植的孤立禁忌证:一项队列研究。
Obesity (Silver Spring). 2021 Sep;29(9):1538-1546. doi: 10.1002/oby.23195. Epub 2021 Aug 2.
10
Kidney recipients with allograft failure, transition of kidney care (KRAFT): A survey of contemporary practices of transplant providers.移植失败的肾移植受者,肾脏护理的过渡(KRAFT):对移植提供者当前实践的调查。
Am J Transplant. 2021 Sep;21(9):3034-3042. doi: 10.1111/ajt.16523. Epub 2021 Apr 12.

肥胖肾移植候选者及受者的管理实践:美国移植项目调查

Practices in the management of kidney transplant candidates and recipients with obesity: A survey of United States transplant programs.

作者信息

Puttarajappa Chethan M, Urbanski Megan, Fallahzadeh M Kazem, Budhiraja Pooja, Balaraman Vasanthi, Butsch W Scott, Morford Harry, Anand Prince M, Woodside Kenneth J, Orandi Babak J

机构信息

Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Department of Surgery, Emory University, Atlanta, Georgia, USA.

出版信息

Am J Transplant. 2025 May 31. doi: 10.1016/j.ajt.2025.05.033.

DOI:10.1016/j.ajt.2025.05.033
PMID:40456410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12228504/
Abstract

There is growing kidney transplant program-level interest in addressing obesity. The American Society of Transplantation Kidney Pancreas Community of Practice Obesity Work Group surveyed US programs to characterize evaluation, listing, and weight management practices. A web-based survey was administered to professionals involved in kidney transplant care (transplant nephrologists/surgeons/coordinators/dietitians, endocrinologists, bariatric surgeons, and obesity medicine specialists) from May 2024 to September 2024. The 275 respondents from 113 programs represented 70.7% of the US transplant volume. A body mass index (BMI) cutoff-commonly 40 kg/m-is used for evaluation/listing at 72.5%/74.3% of programs. For recipients, BMI 40 kg/m was the most common threshold for referral for medical and surgical weight loss. Most (73.4%) programs have weight management programs within their institution; 19.4% have a program integrated into their transplant program. One of the most common reasons for not referring for weight management was a preference that primary care providers/general nephrologists manage this, particularly pretransplant. Of programs, 27.6% offer robotic kidney transplantation; 38.5% offer it only to patients above a BMI threshold (32-40 kg/m). Obesity management is heterogeneous. Most use a BMI cutoff-typically 40 kg/m-for evaluation and listing. These data provide the most comprehensive and contemporary overview of practices at US programs.

摘要

肾脏移植项目层面对于解决肥胖问题的兴趣日益浓厚。美国移植学会肾脏胰腺实践社区肥胖问题工作组对美国各项目进行了调查,以描述评估、列入名单及体重管理的做法。2024年5月至2024年9月,对参与肾脏移植护理的专业人员(移植肾病学家/外科医生/协调员/营养师、内分泌学家、减肥外科医生和肥胖医学专家)进行了一项基于网络的调查。来自113个项目的275名受访者占美国移植量的70.7%。72.5%/74.3%的项目在评估/列入名单时使用体重指数(BMI)临界值——通常为40kg/m²。对于受者,BMI 40kg/m²是转诊进行医学和手术减肥的最常见阈值。大多数(73.4%)项目在其机构内设有体重管理项目;19.4%的项目有一个整合到其移植项目中的项目。不转诊进行体重管理的最常见原因之一是倾向于由初级保健提供者/普通肾病学家来管理,尤其是在移植前。在各项目中,27.6%提供机器人肾脏移植;38.5%仅向BMI高于临界值(32 - 40kg/m²)的患者提供。肥胖管理存在差异。大多数项目在评估和列入名单时使用BMI临界值——通常为40kg/m²。这些数据提供了美国各项目做法最全面和最新的概述。